These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Howe AM; Oakes DJ; Woodman PD; Webster WS Epilepsia; 1999 Jul; 40(7):980-4. PubMed ID: 10403223 [TBL] [Abstract][Full Text] [Related]
5. Acarboxy prothrombin (PIVKA-II) in cord plasma in the south of Thailand. Laosombat V; Kenpitak K; Wongchanchailert M; Wiriyasateinkul A J Med Assoc Thai; 1993 May; 76(5):278-84. PubMed ID: 8006559 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of subclinical vitamin K deficiency in Thai newborns: relationship to maternal phylloquinone intakes and delivery risk. Chuansumrit A; Plueksacheeva T; Hanpinitsak S; Sangwarn S; Chatvutinun S; Suthutvoravut U; Herabutya Y; Shearer MJ Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F104-8. PubMed ID: 19822527 [TBL] [Abstract][Full Text] [Related]
7. Evidence of vitamin K deficiency in cord blood. Mahasandana C; Pung-amritt P; Yodthong S; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():116-20. PubMed ID: 7886551 [TBL] [Abstract][Full Text] [Related]
8. Des-gamma-carboxyprothrombin (PIVKA II) and plasma vitamin K1 in newborns and their mothers. von Kries R; Shearer MJ; Widdershoven J; Motohara K; Umbach G; Göbel U Thromb Haemost; 1992 Oct; 68(4):383-7. PubMed ID: 1448768 [TBL] [Abstract][Full Text] [Related]
9. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Cornelissen M; Steegers-Theunissen R; Kollée L; Eskes T; Vogels-Mentink G; Motohara K; De Abreu R; Monnens L Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):923-8. PubMed ID: 8456903 [TBL] [Abstract][Full Text] [Related]
10. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns. Sharma RK; Marwaha N; Kumar P; Narang A Indian Pediatr; 1995 Aug; 32(8):863-7. PubMed ID: 8635828 [TBL] [Abstract][Full Text] [Related]
11. Mother-infant prothrombin precursor status at birth. Bloch CA; Rothberg AD; Bradlow BA J Pediatr Gastroenterol Nutr; 1984; 3(1):101-3. PubMed ID: 6694038 [TBL] [Abstract][Full Text] [Related]
12. PIVKA-II plasma levels as markers of subclinical vitamin K deficiency in term infants. Dituri F; Buonocore G; Pietravalle A; Naddeo F; Cortesi M; Pasqualetti P; Tataranno ML; Agostino R J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1660-3. PubMed ID: 22280352 [TBL] [Abstract][Full Text] [Related]
13. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route. Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807 [No Abstract] [Full Text] [Related]
14. Hemorrhagic disease of the newborn after maternal anticonvulsant therapy: a case report and literature review. Laosombat V J Med Assoc Thai; 1988 Nov; 71(11):643-8. PubMed ID: 3065431 [No Abstract] [Full Text] [Related]
15. Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Choulika S; Grabowski E; Holmes LB Am J Obstet Gynecol; 2004 Apr; 190(4):882-3. PubMed ID: 15118607 [TBL] [Abstract][Full Text] [Related]
16. [Neonatal hemorrhage following maternal anticonvulsant therapy. Value of vitamin K prophylaxis]. Seip M Tidsskr Nor Laegeforen; 1972 Aug; 92(23):1472-3. PubMed ID: 4673566 [No Abstract] [Full Text] [Related]